KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Cardlytics (CDLX) Shares Issued (2017 - 2024)

Cardlytics filings provide 8 years of Shares Issued readings, the most recent being $11000.0 for Q4 2024.

  • Quarterly Shares Issued changed N/A to $11000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $11000.0 through Sep 2025, down 99.98% year-over-year, with the annual reading at $48.6 million for FY2024, 88345.45% up from the prior year.
  • Shares Issued hit $11000.0 in Q4 2024 for Cardlytics, down from $48.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $484.7 million in Q1 2021 and bottomed at -$18000.0 in Q4 2022.
  • Average Shares Issued over 5 years is $34.1 million, with a median of $349000.0 recorded in 2021.
  • The largest annual shift saw Shares Issued skyrocketed 15312.18% in 2021 before it plummeted 108.0% in 2022.
  • Cardlytics' Shares Issued stood at $3.8 million in 2020, then crashed by 94.09% to $225000.0 in 2021, then plummeted by 108.0% to -$18000.0 in 2022, then soared by 344.44% to $44000.0 in 2023, then tumbled by 75.0% to $11000.0 in 2024.
  • Per Business Quant, the three most recent readings for CDLX's Shares Issued are $11000.0 (Q4 2024), $48.6 million (Q1 2024), and $44000.0 (Q3 2023).